Press Releases
PMC press releases highlight the significance of the Coalition’s activities in education, advocacy, and evidence development.
Clinical Practice Gaps Likely Inhibiting Impact of Personalized Medicine
Personalized Medicine at FDA: The Scope & Significance of Progress in 2022 Documents Pharmaceutical Industry Shift Away from One-Size-Fits-All Drugs
Clinical Practice Gaps Likely Inhibiting Impact of Personalized Medicine
Cost-Effectiveness Estimates for Infants Less Than a Year Old and Children Under Age 18 May Inform Provider and Payer Practices
PMC President: Newly Approved Treatments and Diagnostic Tools ‘Leave No Question’ About Emergence of Era of Personalized Medicine, Presenting Both Opportunities and Challenges for Patients and Health Systems
Representatives From Change Healthcare, Flatiron Health, and Tempus to Discuss Significance of Paper’s Recommendations at 12:00 p.m. ET
Acknowledging Enhanced Benefits of Multi-Gene Testing, Modernized Definition Could Prompt Changes in Clinical Use of Genomic Sequencing-Based Tests
More Than a Number Platform Launches With 13 Articles on Disease Prevention, Diagnosis, and Treatment
Conflicting Information May Deter Clinicians From Ordering Hallmark Personalized Medicine Tests
Multi-factorial Assessment Finds Majority of Health Care Providers Integrating Personalized Medicine into Clinical Care
Report: Agency’s Policies Reinforcing Shift Toward Personalized Medicine Even in Midst of Pandemic
